SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

USPTO Issues Notice of Allowance for IRLAB Drug Candidate Patent

The USPTO issued a notice of allowance for a patent covering IRLAB Therapeutics’ drug candidate IRL1117.

IRLABA

Related stories